• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

用高效液相色谱法和快原子轰击质谱法分析肿瘤定位血卟啉衍生物

Analysis of tumour-localizing haematoporphyrin derivative by high-performance liquid chromatography and fast-atom bombardment mass spectrometry.

作者信息

Meijers J C, Lim C K, Lawson A M, Peters T J

出版信息

J Chromatogr. 1986 Feb 21;352:231-9. doi: 10.1016/s0021-9673(01)83382-3.

DOI:10.1016/s0021-9673(01)83382-3
PMID:3700507
Abstract

Reversed-phase chromatography using a MOS-Hypersil (C8) column with methanol-1 M ammonium acetate buffer (pH 4.6) (60:40) as mobile phase has been developed for the isolation of tumour-localizing haematoporphyrin derivative (HPD). The system effectively resolved the diastereoisomers of haematoporphyrin and its acetyl derivatives. The chromatography peaks were identified by fast-atom bombardment mass spectrometry and were confirmed by chemical synthesis. The main components of HPD before alkaline hydrolysis were diacetylhaematoporphyrin, 8-(1-acetoxyethyl)haematoporphyrin and 3-(1-acetoxyethyl)haematoporphyrin with small amounts of haematoporphyrin, 8-(1-hydroxyethyl)-3-vinyldeuteroporphyrin, 3-(1-hydroxyethyl)-8-vinyldeuteroporphyrin, 8-(1-acetoxyethyl)-3-vinyldeuteroporphyrin, 3-(1-acetoxyethyl)-8-vinyldeuteroporphyrin and protoporphyrin. After hydrolysis with 0.1 M sodium hydroxide, the main components were haematoporphyrin, hydroxyethylvinyldeuteroporphyrins, and protoporphyrin.

摘要

已开发出一种反相色谱法,使用MOS-Hypersil(C8)柱,以甲醇 - 1M醋酸铵缓冲液(pH 4.6)(60:40)作为流动相,用于分离肿瘤定位血卟啉衍生物(HPD)。该系统有效地分离了血卟啉及其乙酰衍生物的非对映异构体。通过快原子轰击质谱法鉴定了色谱峰,并通过化学合成进行了确认。碱性水解前HPD的主要成分是二乙酰血卟啉、8-(1-乙酰氧基乙基)血卟啉和3-(1-乙酰氧基乙基)血卟啉,还有少量的血卟啉、8-(1-羟乙基)-3-乙烯基去氢卟啉、3-(1-羟乙基)-8-乙烯基去氢卟啉、8-(1-乙酰氧基乙基)-3-乙烯基去氢卟啉、3-(1-乙酰氧基乙基)-8-乙烯基去氢卟啉和原卟啉。用0.1M氢氧化钠水解后,主要成分是血卟啉、羟乙基乙烯基去氢卟啉和原卟啉。

相似文献

1
Analysis of tumour-localizing haematoporphyrin derivative by high-performance liquid chromatography and fast-atom bombardment mass spectrometry.用高效液相色谱法和快原子轰击质谱法分析肿瘤定位血卟啉衍生物
J Chromatogr. 1986 Feb 21;352:231-9. doi: 10.1016/s0021-9673(01)83382-3.
2
In vivo biological activity of the components of haematoporphyrin derivative.血卟啉衍生物各成分的体内生物活性。
Br J Cancer. 1982 Apr;45(4):571-81. doi: 10.1038/bjc.1982.94.
3
Uptake and localisation of haematoporphyrin derivative in normal rat liver.
Biochem Pharmacol. 1987 Sep 1;36(17):2759-64. doi: 10.1016/0006-2952(87)90261-9.
4
On the nature of the active component of haematoporphyrin derivative--Part 2.
Cancer Lett. 1987 Dec;38(1-2):9-14. doi: 10.1016/0304-3835(87)90194-7.
5
NMR study on the major components in hematoporphyrin derivative YHPD.
Sci China B. 1989 Apr;32(4):442-57.
6
Identification of porphyrin modified photosensitizer porfimer sodium and its precursors by high performance liquid chromatography and mass spectrometry.通过高效液相色谱和质谱法鉴定卟啉修饰的光敏剂卟吩姆钠及其前体。
J Chromatogr A. 2007 Mar 23;1145(1-2):141-8. doi: 10.1016/j.chroma.2007.01.071. Epub 2007 Jan 26.
7
Haematoporphyrin derivatives: distribution in a living organism.血卟啉衍生物:在生物体内的分布
J Photochem Photobiol B. 1992 Dec;16(3-4):341-6. doi: 10.1016/1011-1344(92)80021-m.
8
The composition of Photofrin II.光敏素II的成分。
J Photochem Photobiol B. 1990 Jun;6(1-2):13-27. doi: 10.1016/1011-1344(90)85070-d.
9
Photosensitization with derivatives of haematoporphyrin.血卟啉衍生物的光敏作用。
Int J Radiat Biol Relat Stud Phys Chem Med. 1986 Jun;49(6):901-7. doi: 10.1080/09553008514553131.
10
The analysis and some chemistry of haematoporphyrin derivative.血卟啉衍生物的分析及一些化学性质
Prog Clin Biol Res. 1984;170:285-300.

引用本文的文献

1
Evidence for the direct desorption of crown ether-metal ion complexes in liquid secondary Ionization Mass Spectrometry.在液体二次离子质谱中,冠醚-金属离子配合物的直接解吸证据。
J Am Soc Mass Spectrom. 1994 Jul;5(7):638-48. doi: 10.1016/1044-0305(94)85005-4.